Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Seres Therapeutics Inc (NQ: MCRB ) 0.8707 +0.0007 (+0.08%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 31,107 Open 0.8707 Bid (Size) 0.8800 (4) Ask (Size) 0.9200 (10) Prev. Close 0.8700 Today's Range 0.8707 - 0.8707 52wk Range 0.5400 - 3.670 Shares Outstanding 127,901,391 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q2 2024 August 13, 2024 MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace MCRB Investigation Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Seres Therapeutics, Inc. Assets Is Fair to Shareholders August 09, 2024 From Halper Sadeh LLC Via Business Wire Performance YTD -37.81% -37.81% 1 Month -34.04% -34.04% 3 Month -6.33% -6.33% 6 Month -18.63% -18.63% 1 Year -75.54% -75.54% More News Read More 12 Health Care Stocks Moving In Monday's Intraday Session June 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 09, 2024 Via Benzinga Seres Therapeutics's Earnings: A Preview March 04, 2024 Via Benzinga Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 08, 2024 Via Benzinga MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q1 2024 May 08, 2024 Via InvestorPlace Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 08, 2024 Via Benzinga Nasdaq Down Over 50 Points; Uber Posts Q1 Loss May 08, 2024 Via Benzinga Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates May 08, 2024 From Seres Therapeutics, Inc. Via Business Wire Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 06, 2024 From Seres Therapeutics, Inc. Via Business Wire Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024 May 06, 2024 From Seres Therapeutics, Inc. Via Business Wire Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT April 09, 2024 From Seres Therapeutics, Inc. Via Business Wire Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 28, 2024 From Seres Therapeutics, Inc. Via Business Wire Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 19, 2024 From Seres Therapeutics, Inc. Via Business Wire Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday March 06, 2024 Via Benzinga Gold Price Alert: Gold Spot Prices Just Hit a Record High Today March 05, 2024 Via InvestorPlace MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q4 2023 March 05, 2024 Via InvestorPlace Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates March 05, 2024 From Seres Therapeutics, Inc. Via Business Wire Earnings Scheduled For March 5, 2024 March 05, 2024 Via Benzinga Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024 February 28, 2024 From Seres Therapeutics, Inc. Via Business Wire Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference February 27, 2024 From Seres Therapeutics, Inc. Via Business Wire Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz February 26, 2024 From Seres Therapeutics, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
